Gliotoxin: Difference between revisions
m (Protected "Gliotoxin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 89: | Line 89: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Gliotoxin''' is a [[sulfur|sulfur-containing]] [[antibiotic]] produced by some unrelated species of [[pathogen|pathogenic]] [[fungus|fungi]], such as ''[[Aspergillus]]'', ''[[Trichoderma]]'', and ''[[Penicillium]]'', and by the [[yeast]] ''[[Candida (genus)|Candida]]''. It was originally isolated from ''Gliocladium fimbriatum'', and was named accordingly. It is an epipolythiodioxopiperazine metabilite. | '''Gliotoxin''' is a [[sulfur|sulfur-containing]] [[antibiotic]] produced by some unrelated species of [[pathogen|pathogenic]] [[fungus|fungi]], such as ''[[Aspergillus]]'', ''[[Trichoderma]]'', and ''[[Penicillium]]'', and by the [[yeast]] ''[[Candida (genus)|Candida]]''. It was originally isolated from ''Gliocladium fimbriatum'', and was named accordingly. It is an epipolythiodioxopiperazine metabilite. | ||
| Line 108: | Line 108: | ||
[[Category:Immunosuppressive agents]] | [[Category:Immunosuppressive agents]] | ||
[[de:Gliotoxin]] | [[de:Gliotoxin]] | ||
Revision as of 15:33, 9 August 2012
|
WikiDoc Resources for Gliotoxin |
|
Articles |
|---|
|
Most recent articles on Gliotoxin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Gliotoxin at Clinical Trials.gov Clinical Trials on Gliotoxin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Gliotoxin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Gliotoxin Discussion groups on Gliotoxin Directions to Hospitals Treating Gliotoxin Risk calculators and risk factors for Gliotoxin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Gliotoxin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Gliotoxin is a sulfur-containing antibiotic produced by some unrelated species of pathogenic fungi, such as Aspergillus, Trichoderma, and Penicillium, and by the yeast Candida. It was originally isolated from Gliocladium fimbriatum, and was named accordingly. It is an epipolythiodioxopiperazine metabilite.
Gliotoxin possesses immunosuppressive properties as it may suppress and cause apoptosis in certain types of cells of the immune system, including neutrophils, eosinophils, and granulocytes. Causes apoptosis in macrophages and thymocytes. It also acts as an inhibitor of farnesyl transferase. It noncompetitively inhibits the chymotrypsin-like activity of the 20S proteasome. In vivo it displays anti-inflammatory activity.[1] It acts by blocking thiol groups in the cell membranes.
References
- Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro: A. Müllbacher, et al.; J. Gen. Microbiol. 131, 1251 (1985)
- R.J. Jones & J.G. Hancock; J. Gen. Microbiol. 134, 2067 (1988) Gliotoxin stimulates Ca2+ release from intact rat liver mitochondria: M. Schweizer & C. Richter; Biochemistry 33, 13401 (1994)
- Extracellular calcium is not required for gliotoxin or dexamethasone- induced DNA fragmentation: a reappraisal of the use of EGTA: P. Waring & A. Sjaarda; Int. J. Immunopharmacol. 17, 403 (1995)
External links
Gliotoxin product page from Fermentek